PER 2.44% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study, page-20

  1. 4,645 Posts.
    lightbulb Created with Sketch. 696
    It's not a "bad" announcement, IF ANP had a "cleaner historical profile" with investors, it would actually be considered rather good news indeed - of course, viewing it from the perspective, as a positive or a negative the reality is, it's the start of a longer-term journey. But not a "bad" announcement....there is now a real corporate heartbeat.....at least!

    Certainly the RNAi space is truly hotting up, so this may yet emerge as a still interesting situation.......
    Last edited by Moreforme: 02/10/17
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $58.49K 703.3K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 25545 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.